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The endocannabinoid (eCB) system possesses neuromodulatory functions by
influencing the release of various neurotransmitters, including γ-aminobutyric acid
(GABA) and glutamate. A functional interaction between eCBs and the serotonergic
system has already been suggested. Previously, we showed that cannabinoid type-1
(CB1) receptor mRNA and protein are localized in serotonergic neurons of the raphe
nuclei, implying that the eCB system can modulate serotonergic functions. In order to
substantiate the physiological role of the CB1 receptor in serotonergic neurons of the
raphe nuclei, we generated serotonergic 5-hydroxytryptamine (5-HT) neuron-specific
CB1 receptor-deficient mice, using the Cre/loxP system with a tamoxifen-inducible
Cre recombinase under the control of the regulatory sequences of the tryptophan
hydroxylase 2 gene (TPH2-CreERT2), thus, restricting the recombination to 5-HT neurons
of the central nervous system (CNS). Applying several different behavioral paradigms, we
revealed that mice lacking the CB1 receptor in serotonergic neurons are more anxious
and less sociable than control littermates. Thus, we were able to show that functional
CB1 receptor signaling in central serotonergic neurons modulates distinct behaviors in
mice.
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Introduction
Serotonin (5-hydroxytryptamine, 5-HT) is present in many central and peripheral tissues, where it
functions as a neurotransmitter or hormone. In the brain, 5-HT neurons are located in midbrain
and brainstem areas, called raphe nuclei (Baker et al., 1991; Carkaci-Salli et al., 2011). Projections
from the raphe nuclei innervate nearly every region of the central nervous system (CNS), including
cortex, hippocampus, amygdala, striatum, hypothalamus, and spinal cord. This broad anatomical
distribution is in line with the diverse behavioral functions which are modulated by serotonergic
signaling.
A similarly wide distribution can be seen by the cannabinoid type-1 (CB1) receptor, a central
component of the endocannabinoid (eCB) system controlling synaptic activity (Kano et al.,
2009). To date, the presence of functional CB1 receptor has been verified in several important
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neurotransmitter systems, including the GABAergic,
glutamatergic, noradrenergic, cholinergic and serotonergic
neurons (e.g., Kathmann et al., 1999; Marsicano and Lutz, 1999;
Hájos and Freund, 2002;Wallmichrath and Szabo, 2002; Monory
et al., 2006; Häring et al., 2007; Ruehle et al., 2013; Ramikie et al.,
2014).
Several investigations have evidenced that the eCB system can
modulate the serotonergic system, suggesting a basis for new
approaches for the treatment of anxiety disorders (Haj-Dahmane
and Shen, 2011). Both eCBs and 5-HT have been shown to
influence numerous physiological functions and to control a wide
range of behaviors and emotional states (Häring et al., 2012;
Ruehle et al., 2012; Asan et al., 2013; Bellocchio et al., 2013;
Hanks and González-Maeso, 2013). Importantly, their functional
interaction could be verified at the behavioral level. Specific
cannabinoid-induced emotional changes were shown to depend
on functional 5-HT transmission (Gobbi et al., 2005; Bambico
et al., 2007; Häring et al., 2013).
It is believed that serotonin transmission is modulated via
the activation of glutamatergic CB1 receptor in the dorsal
raphe nucleus (DRN), with focus on the prefrontal cortex
(PFC)–DRN pathway (Gobbi et al., 2005; Haj-Dahmane and
Shen, 2005; Bambico et al., 2007; Haj-Dahmane and Shen,
2009). Interestingly, the systematic administration of URB597,
an inhibitor of fatty acid amide hydrolase (FAAH), can enhance
the firing of serotonergic neurons in DRN and increase the
hippocampal levels of 5-HT (Gobbi et al., 2005). This effect
is mimicked by local injection of CB1 receptor agonists into
the PFC and blocked by PFC transection (Bambico et al.,
2007). Hence, the eCB system seems to control PFC circuits
which modulate the signaling toward the DRN. Furthermore,
local activation of CB1 receptor in the DRN reduces the
strength of glutamatergic inputs onto DRN 5-HT neurons,
suggesting that CB1 receptor-positive glutamatergic synapses
control serotonergic neuron activity within this region (Haj-
Dahmane and Shen, 2005, 2009).
A potential direct interaction between the eCB system and
the serotonergic system has already been suggested by other
studies as well. Global loss of the CB1 receptor reduced the
responsiveness of mice to the anxiolytic drug buspirone, a
serotonin receptor 5-HT1A agonist (Urigüen et al., 2004). In
vitro studies showed that the release of 5-HT can be altered by
the cannabinoid CB1/CB2 receptor agonist WIN552122 and by
the CB1 receptor antagonist rimonabant in mouse cortical slices
(Nakazi et al., 2000). Furthermore, we identified expression of the
CB1 receptor in serotonergic neurons at the mRNA and protein
level (Häring et al., 2007), suggesting that (endo)cannabinoids
may directly regulate 5-HT transmission. Finally, the CB1
receptor co-localizes with the serotonin transporter (SERT)
and can control frontocortical 5-HT release (Ferreira et al.,
2012).
The question has remained whether the low levels of CB1
receptor expression we observed in serotonergic neurons are
functionally important in the context of the animal’s behavior.
Here, the physiological role of the CB1 receptor in central
serotonergic neurons was analyzed by generating mutant mice
with a specific loss of the CB1 receptor gene in central 5-HT
neurons. To this end, floxed CB1 receptor mice (Marsicano et al.,
2003) were crossed with a transgenic mouse line expressing
the tamoxifen-inducible Cre recombinase under the control of
the regulatory elements of the tryptophan hydroxylase-2 gene
(TPH2-CreERT2; Weber et al., 2009). This mouse line allows
temporal control over the recombination event, thereby avoiding
potential compensatory processes caused by developmental
effects. Following treatment with tamoxifen during adulthood,
molecular and behavioral analyses of mutants (TPH2-CB1−/−)
and wild-type (TPH2-CB1+/+) littermates were performed.
Specifically, we investigated whether CB1 receptor-expressing
5-HT neurons in the raphe nuclei influence anxiety, social
interaction, and acute stress coping.
Materials and Methods
Breeding Strategy
Experimental protocols were carried out in accordance with
the Council Directive 2010/63EU of the European Parliament
and the Council of 22 September 2010 on the protection of
animals used for scientific purposes and approved by the Ethical
Committee on animal care and use of Rhineland-Palatinate,
Germany (reference number 23 177-07/G 08-1-021).
The conditional mutant mouse line, named TPH2-CB1−/−
after tamoxifen-induced recombination, in which the CB1
receptor is deleted from central 5-HT neurons, was generated
by a three-step process. As a first step, homozygous CB1fl/fl
female mice (Marsicano et al., 2003) were crossed with
males bearing a tamoxifen-inducible CreERT2 recombinase
expressed under the regulatory elements of the mouse TPH2
gene (TPH2CreERT2; Weber et al., 2009). In a second step,
heterozygous CB1fl/+; tph2−CreERT2tg/+ mice were crossed with
CB1fl/fl mice to obtain CB1fl/fl; tph2−CreERT2tg/+ mice. At last, male
CB1fl/fl; tph2−CreERT2tg/+ mice were bred with CB1fl/fl females to
generate the experimental animals CB1fl/fl; tph2−CreERT2tg/+, after
tamoxifen-induced recombination referred to as TPH2-CB1−/−.
CB1fl/fl served as littermate controls and were also treated with
tamoxifen, referred to as TPH2-CB1+/+.
To exclude potential behavioral impacts of the TPH2-
CreERT2 transgene, additional experiments were performed
using heterozygous transgenic TPH2CreERT2tg/+ mice and their
wild-type littermates containing no transgene.
Genotyping
Genotyping was performed by polymerase chain reaction (PCR)
from tail genomic DNA using the forward primer 5′-CGGCA
TGGTG CAAGT TGAAT A-3′ (G100) and the reverse primer
5′-GCGAT CGCTA TTTTC CATGA G-3′ (G101) for the
detection of the Cre recombinase locus, yielding a 400 bp band.
The floxed CB1 receptor allele was detected using a forward
primer 5′-GCTGT CTCTG GTCCT CTTAA A-3′ (G50) and a
reverse primer 5′-GGTGTCACCTCTGAAAACAGA-3′ (G51).
Using these primers, wild-type alleles give an amplicon of 413
bp, whereas targeted (floxed) alleles give a 493 bp amplicon. The
evaluation of both loci was done simultaneously in one PCR
reaction (1 × 95◦ for 3 min; 37 × [95◦C for 1 min; 54◦C for 1
min; 72◦C for 1 min]; 1× 72◦C for 5 min).
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Induction of Recombination
Due to the mutated ligand binding domain of the estrogen
receptor (ERT2) fused to the Cre recombinase, tamoxifen had to
be injected to allow translocation of CreERT2 into the nucleus,
where the activated enzyme induced recombination of the floxed
CB1 receptor allele. To this end, animals were intraperitoneally
(i.p.) injected with either vehicle or tamoxifen (freshly prepared;
2 mg/day/mouse) once per day for 5 days at the age of 10–17
weeks. Vehicle solution consisted of 90% sun flower seed oil and
10% ethanol (Sigma Aldrich). For behavioral experiments, all
animals were treated with tamoxifen to exclude any treatment
induced effect.
Evaluation of Recombination by Genomic PCR in
Tissue Sections
One week after the last tamoxifen injection, mice were sacrificed
by decapitation after isoflurane anesthesia. The brain and
duodenum were removed. By using a brain matrix, the brain
was cut into 1 mm sections. Using a 1 mm puncher, several
brain regions were isolated. The duodenum was rinsed in 1 ×
PBS to remove digested material. For brain and duodenum
tissue, DNA isolation was performed as follows: Samples were
treated overnight at 56◦C in 500 µl lysis buffer (100 mM
Tris-HCl pH 8, 5 mM EDTA, 200 mM NaCl, 0.2% SDS)
and 10 µl proteinase K (10 mg/ml stock concentration) in a
shaking (800 rpm) thermomixer (Eppendorf). On the next day,
the probes were centrifuged for 2 min at 13,000 rpm. The
supernatant was collected and mixed by inversion with 500
µl phenol/chloroform mixture (Sigma cat P2069). Following
another centrifugation step for 5 min at 13,000 rpm, the upper
(aqueous) phase was transferred and mixed by inversion with
500 µl chloroform. The probes were again centrifuged for 5 min
at 13,000 rpm. Subsequently, the supernatant was transferred,
mixed by inversion with 500 µl isopropanol and centrifuged for
5 min at 13,000 rpm. The supernatant was completely removed,
and the pellet was washed with 70% ethanol by centrifugation for
5 min at 13,000 rpm. After removing the supernatant, the pellet
was air dried at RT for 10 min and dissolved in 20 µl PCR grade
H2O. The DNA was tested for the recombination event by PCR
reaction (1 × 95◦ for 3 min, 37 × [95◦C for 1 min; 54◦C for 1
min; 72◦C for 1 min], 1 × 72◦C for 5 min) using the forward
primer 5′-GCTGT CTCTG GTCCT CTTAA A-3′ (G50) and the
reverse primer 5′-CTCCT GTATG CCATAG CTCTT-3′ (G53),
obtaining a 600 bp band.
In situ Hybridization
In order to visualize theminute amounts of CB1 mRNA in central
serotonergic neurons and thus verify successful recombination
in situ in TPH2-CB1−/− mice, we employed a highly sensitive
in situ hybridization (ISH) system (ViewRNATM ISH Tissue 2-
Plex Assay; Affymetrix). Four weeks after tamoxifen injections,
mice were sacrificed and brains were isolated. Three mm thick
tissue blocks were cut using a brain matrix approximately
from −3.5 to −6.5 mm from the bregma. Tissue was fixed
with 4% paraformaldehyde for 16–24 h, rinsed, dehydrated
and embedded in a paraffin block. Paraffin-embedded tissue
blocks were sectioned at a thickness of 6 µm and mounted
on Fisherbrand Superfrost Plus Slides (Thermo Scientific), air-
dried at 37◦C for 5 h and stored at 4◦C. Slides were baked
at 60◦C overnight and then dewaxed in xylene. Following heat
pretreatment with pretreatment solution at 85–90◦C for 10
min, the tissue was digested with Protease QF (Affymetrix)
for 10 min and then hybridized with QuantiGene ViewRNA
probes (Mouse Cnr1 Type 1, NM_007726, VB1-10422; Mouse
Tph2 Type 6, NM_173391, VB6-16623; Mouse Ubc Type
1, NM_019639, VB1-10202; Affymetrix). Bound probes were
pre-amplified and subsequently amplified according to the
manufacturer’s guidelines. Probe oligonucleotides of Label Type
1 conjugated to alkaline phosphatase were added followed by
Fast Red substrate. Subsequently, probe oligonucleotides of Label
Type 6 conjugated to alkaline phosphatase were added followed
by the Fast Blue substrate. Afterwards, slides were cover-slipped
with Mowiol mounting medium. Images were acquired using a
Leica DM5500B microscope (Leica).
General Outline of Behavioral Experiments
Animals were group housed (3–5 animals per cage) in a
temperature- and humidity-controlled room with a 12 h light-
dark cycle (lights on at 1 am). Adult males were treated with
tamoxifen (2 mg/day for 5 days i.p.) between 10–17 weeks of
age to induce recombination in order to obtain TPH2-CB1+/+
and TPH2-CB1−/− mice. An interval of at least 3 weeks ensured
the degradation of the CB1 receptor transcript and protein and
prevented stress-induced behaviors due to tamoxifen injection
(Vogt et al., 2008). In the 3rd week, mice were single housed to
avoid behavioral differences between dominant and subordinate
animals. Behavioral analyses started 4 weeks after the treatment.
If not stated otherwise, experiments were performed 1 h after
turning off the lights (at 2 pm) in the active phase of the animals,
with only a dim red light source in the room (0 lux).
After each test, the equipment used was cleaned with 70%
ethanol and then with water. Experiments were recorded on
DVD, and the behavioral performance was evaluated by hand
(EPM, FST, LD, NORT, NSF and RI) or SMART software
(Panlab, Spain; Sociability and Open field, OF).
Behavioral Tests
Animals were tested in a battery of behavioral tests, which were
performed in the order in which they are described below. The
tests Open field, Light Dark (LD), Novelty Suppressed Feeding
(NSF), Marble Burying and Elevated Plus Maze (EPM) were
performed within 1 week, always with 24 h in between the tests.
In order to minimize the potential effect of stress due to the
test battery, animals were left undisturbed for 1 week before
continuing with the RotaRod test and the Forced Swim Test
(FST). For the Social and Object interaction paradigms, separate
batches were used.
Open Field
To evaluate locomotor activity, an open field test was performed.
The test was conducted in a plastic open field chamber (41 cm×
42 cm × 40 cm [Height ×Width × Length]) and total distance
moved, distance in periphery vs. center and time in periphery vs.
center were measured.
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Light Dark Test
By running the light dark test (LDT), basic anxiety-like behavior
was investigated using a box with one open white compartment
(40 × 26 × 38.5 cm [H × L × W]) and one closed black
compartment (40 × 13 × 38.5 cm [H × L ×W]) connected via
an entrance. The animal was allowed to move freely between the
two compartments. Experiments were performed during the light
phase (200 lux above floor of lit compartment). The animal was
placed directly in front of the entrance in the lit compartment. As
soon as the animal had entered the closed compartment, a 5 min
test period was started. The entries into the lit compartment, the
time spent in the lit compartment, as well as risk assessment
behavior, were evaluated. Risk assessment includes a stretch-
attend posture in which the head and fore-paws of the animal
extend into the lit area but the remainder of the body stays in the
dark compartment (Bailey and Crawley, 2009).
Novelty Suppressed Feeding
The NSF paradigm measures basic anxiety-like behavior with
acute food intake and body weight development (Bodnoff et al.,
1989). The test was performed in a brightly lit (450 lux) white
plastic box (40 cm × 80 cm × 80 cm [H ×W × L]). The floor
was covered with a thin layer of saw dust. To avoid disturbing
the light-dark cycle, this test was performed during the light
phase. A food pellet was placed on an 18-cm filter paper in
the center of the box. When the test started, the animal had
been food deprived for 24 h, in order to increase the drive
towards the food pellet presented. The animal was placed into
the box for a maximum time of 10 min. Time was measured
until the animal first touched the food pellet and until the
mouse started eating. When the animal had started eating, it
was placed back into the home cage with food ad libitum.
Food consumption was measured at different time points (5
min, 30 min, 1 h, 2 h, 4 h, 8 h and 24 h after returning to
home cage).
Marble Burying Test
This test is assessing the anxiety response to novel stimuli (here:
marbles) without the possibility of retreat. A standard cage was
filled with 3–4 cm of saw dust. The test mouse was placed into
the cage where 12marbles had been evenly distributed on the saw
dust (Broekkamp et al., 1986). The animal was allowed to move
freely in the cage for 15 min. At the end of the test, the number of
buried marbles was recorded. A high number of marbles buried
is regarded as increased anxiety behavior.
Elevated Plus Maze
This assay is measuring anxiety in mice. The EPM, a crossed
platform of two closed and two open arms made of white plastic,
is 100 cm above the ground. All four arms are of 35 cm length
and 6 cm width. The closed arms have additional black plastic
walls of 20 cm height. The animal was placed into the center of
the EPM and was allowed to explore the maze freely for a 5 min
period. Time spent on the different arms and arm entries were
measured.
RotaRod
To evaluate motor skills, animals were tested on the RotaRod
apparatus from Ugo Basile (38 × 32 × 44 cm [H × L × W])
during a 5 day protocol. The speed of the rod accelerated from
4–50 rpm (max. speed was reached after 180 s. Time and speed
until the animal fell down were registered setting a 210 s cutoff
time. Mice were tested three times a day with resting intervals of
5 min between the trials.
Sociability Test
This test was performed using a modified protocol taken from
Moy et al. (2004). In short, the test chamber (41 cm× 42 cm× 70
cm [H ×W × L]) was divided into three compartments (40 cm
× 40 cm × 22 cm [H × L × W]), all accessible by openings
(7.5 cm × 10 cm [H × W]) in the dividing walls. Chambers
and cages were cleaned with 70% ethanol between each trial
to avoid olfactory cues. The total time the test animals spent
in each of the compartments during the sociability and social
novelty phase was measured. Male C57BL/6N animals (10–12
weeks old) were used as interaction partners in both of the
test phase. Habituation Phase: The test animal was placed into
the middle compartment for 5 min with entries to the side
compartments blocked. Sociability Phase: After the habituation
phase, the blockades of the entries were removed, allowing free
access to the side compartments. The test animal was thereby
exposed to a novel C57BL/6N interaction partner and a novel
object (round cage described below) each positioned in one of the
two side compartments. The position of the interaction partner
(left vs. right compartment) was alternated between trials to
avoid any bias. The interaction partner itself was enclosed in
a round cage (10 cm in diameter; 30 cm high [upper 20 cm
Plexiglas, lower 10 cm covered by metal bars 1 cm apart to
allow interaction but prevent fighting]). Tominimize stress levels
of these animals, they were habituated to the cages four times
for 10 min. Furthermore, they were equally used for wild-type
and mutant test mice to counterbalance individual behavioral
differences.
Novel Object Recognition Task
The novel object recognition task (NORT) combines a general
exploration test with a visual recognition memory paradigm.
The test was performed in a white plastic open field chamber
(40 cm × 40 cm × 40 cm [H × W × L]). The protocol used
was modified after Ennaceur and Delacour (1988), Tang et al.
(1999) and Tordera et al. (2007). For habituation, the animals
were placed into the empty open field and allowed to explore
the box for 10 min once a day for 2 days. On day three, two
identical objects (O1 left, and O1 right; two metal cubes with
4 cm × 3 cm × 5 cm dimensions [H × W × L]) were placed
symmetrically 6–7 cm from the walls with a separation distance
of 16–18 cm from each other. The mouse was placed into the
box at an equal distance from both objects and it was video-
recorded for 10 min. After this first exposure to the object, the
mouse was returned to its home cage. 2 h and 24 h later, the
mouse was placed into the open field again. During these 10
min retention trials, it was exposed to the familiar object (O1),
as well as to a novel object (O2 for the 2 h time point, and O3
Frontiers in Behavioral Neuroscience | www.frontiersin.org 4 September 2015 | Volume 9 | Article 235
Häring et al. Behavioral functions of serotonergic CB1
for the 24 h time point, respectively). The novel object O2 was a
plastic billiard ball (5.72 cm in diameter) fixed on a metal plate
(0.2 cm [H]), O3 was a round glass flask (6 cm × 3 cm [H ×
W]) filled with sand and sealed with a black rubber plug. The
familiar object was always positioned on the left side, while the
new object was on the right side. Box and objects were cleaned
with 70% ethanol after each trial to avoid olfactory cues. The
experiment was video-recorded and the total time that the animal
spent exploring each of the two objects in training and retention
phase was evaluated by an experimenter blind to the genotype.
Object exploration was defined by orienting the nose directly to
the object at a distance <2 cm and/or touching the object with
nose and whiskers. Time spent climbing and sitting on the object
was not regarded as exploration as it rather represents a form
of environment investigation. Therefore, it was excluded from
measurement (Ennaceur and Delacour, 1988).
Resident Intruder Test
This paradigm allows evaluation of social exploration and
aggressive behavior (Goyens and Noirot, 1975). The resident-
intruder test was performed by placing a novel, group housed
intruder into the home cage of the test animal for 10 min.
To decrease interaction induced by the intruder, younger
animals (males, 11–13 weeks of age) were used as intruders.
The experiment was video recorded, and the total interaction
time of the animals spent exploring was measured by an
experimenter blind to the genotype. Interaction was defined
by any type of physical interaction clearly directed towards
the partner. Duration and number of fights were evaluated
separately. Fighting was defined by physical struggling between
the interaction partners, initiated by an attack of the resident
towards the intruder.
Forced Swim Test
The paradigm was performed in a round glass beaker (18 cm in
diameter; 35 cm [H]) filled with tap water at 25◦C +/−0.5◦C.
The water level was approximately 20 cm to prevent the animal
from touching the bottom of the glass or climbing off of the
beaker. The animal was carefully lowered into the water and
recorded on DVD for 6 min. The first 2 min were not evaluated;
however, floating behavior was scored for the following 4 min
by an experimenter blind to genotype. Floating was defined by
immobility of the animal with only minimal movements to keep
body balance.
Corticosterone Measurements
5-HT is known to influence the hypothalamus-pituitary-adrenal
axis. Thus, plasma corticosterone levels were measured in non-
stressed (immediately killed after removal from home cage) and
stressed (killed 5 min after FST paradigm) animals (Steiner et al.,
2008). Mice were decapitated between 3 pm and 5 pm, and the
blood was collected in EDTA di-calcium containing collection
tubes (KABE Labortechnik, Nümbrecht). Plasma was separated
from blood cells by centrifugation at 13,000 rpm for 5 min at 4◦C
and was stored until use at−20◦C. Corticosterone concentration
was analyzed using the Corticosterone EIA Kit (IBL, Hamburg)
and measured by the FLUOstar Galaxy from BMG Labtech.
Statistical Analysis
Data are presented as mean ± standard error of the mean
(SEM) of individual data points. Results were considered to
be significant at p < 0.05. Behavioral endpoints were initially
analyzed using unpaired Student’s t-test or two-way ANOVA,
using genotype and object as factors and Bonferroni post-tests
to correct for multiple comparisons.
Results
CB1 Receptor Gene Inactivation in Serotonergic
Neurons of the Raphe Nuclei
In order to induce a deletion of the CB1 receptor gene in
central serotonergic neurons, CB1fl/fl mice were crossed with the
TPH2CreERT2tg/+ transgenic mice. Experimental animals, lacking
CB1 in 5-HT neurons after tamoxifen treatment, were named
TPH2-CB1−/− and their control CB1fl/fl littermates were named
TPH2-CB1+/+.
Deletion of the CB1 receptor gene in TPH2-CB1−/− mice
was detected only in genomic DNA isolated from the area
of the raphe nuclei, but not from other brain regions or
duodenum (Bellocchio et al., 2013), indicating a region-specific
loss of the CB1 receptor gene. Therefore, we have isolated
genomic DNA from brain punches of the raphe nuclei region of
tamoxifen-treated and vehicle-treated TPH2-CB1−/− and TPH2-
CB1+/+ mice, respectively. Using primers located on the left
and right homology arms (G50 and G53; Figure 1A), incidence
of successful recombination events was tested by the presence
of a 600 bp band. We were only able to detect this band in
mice that expressed Cre recombinase in 5-HT neurons (TPH2-
CB1−/−) and were treated with tamoxifen (Figure 1B), indicating
the absence of background recombination without tamoxifen
treatment in these mice.
Cell-type specific deletion of the CB1 receptor gene in TPH2-
CB1−/− mice was further verified by ISH with CB1 and TPH2
probes (Figure 2). TPH2 probes were used to define serotonergic
neurons. In accordance with our previous study (Häring et al.,
2007), we found CB1 receptor mRNA in a subpopulation of
serotonergic neurons in TPH2-CB1+/+ mice. Furthermore, the
expression levels for CB1 mRNA were very low in this cell
population. Tamoxifen-induced recombination resulted in a
≥90% decrease of the number of CB1-positive serotonergic
neurons in TPH2-CB1−/− mice.
No Alterations in Locomotor Activity and Motor
Skills
The evaluation of motor skills in the RotaRod test revealed
that both genotypes improved their performance during the
5 days of training, but there were no differences between
genotypes (Time spent on rod on day 5: 101.07 ± 6.169 s for
TPH2-CB1−/− [n = 23] and 85.57 ± 7.69 s for TPH2-CB1+/+
[n = 24]; genotype effect [F(1,630) = 0.61; p = 0.4384]; time
effect [F(14,630) = 40.02; p < 0.001]). Moreover, no difference
was observed for the locomotor activity in the open field and
in the sociability test (Open Field: 2899 ± 92.35 cm for TPH2-
CB1−/− [n = 42] and 2846± 118.4 cm forTPH2-CB1+/+ [n = 50];
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FIGURE 1 | Tamoxifen-inducible genetic inactivation of cannabinoid type 1 (CB1) receptor in TPH2-positive neurons. (A) Schematic illustrations of CB1fl/fl
allele before (above) and after Cre recombinase-mediated recombination (below). Arrows indicate primer positions. (B) Applying primers G50/G53, polymerase chain
reaction (PCR) reactions were run using genomic DNA from the raphe nuclei region as a template. The 600 bp band indicating successful recombination was only
detected in mice containing the CreERT2 transgene. (Cre+) after treatment with tamoxifen (+Tam). LA, left homology arm; RA, right homology arm; Cre+, animals
heterozygous for the CreERT2 transgene and homozygous for the CB1fl/fl allele. Cre- = CB1fl/fl mice without the CreERT2 transgene; +Tam, tamoxifen-treated; −Tam,
vehicle-treated; M, DNA size marker.
[T(90) = 0.3604; p = 0.719]; Sociability-Habituation: 930.7 ±
48.96 cm for TPH2-CB1−/− [n = 18] and 1096 ± 53.47 cm
for TPH2-CB1+/+ [n = 201]; [T(369) = 1.91337; p = 0.0637],
Sociability phase: 4436 ± 82 cm for TPH2-CB1−/− [n = 18] and
4680 ± 167 cm for TPH2-CB1+/+ [n = 21]; [T(37) = 0.1458;
p = 0.1539]).
No Alterations in Basal Anxiety-Like Behavior
The basic anxiety response was evaluated using the LDT and
EPM, two established and acknowledged anxiety paradigms.
However, none of these tests revealed any genotype differences.
In the LDT, risk assessment, entries into the lit compartment,
and the time spent in the lit compartment were not different
in the TPH2-CB1−/− as compared to TPH2-CB1+/+ littermates
(entries [T(88) = 0.2126; p = 0.8321]; risk assessment [T(88)
= 0.1184; p = 0.9060]; time spent in the lit compartment
[T(1,88) = 0.5223; p = 0.6028]; Figure 3A). Similarly, no
differences between genotypes were detected in the EPM
regarding the percentage of time spent and entries on the
open arm (time [T(88) = 0.2288; p = 0.8195]; entries [T(88) =
0.5616; p = 0.5758]; Figure 3B). Furthermore, in the marble
burying test, likewise an anxiety paradigm, no difference
in the number of marbles buried was observed (4.531 ±
0.6350 marbles for TPH2-CB1−/− [n = 32] and 5.938 ±
0.7239 marbles for TPH2-CB1+/+ [n = 32]; T(62) = 1.490;
p = 0.1492).
Increased Aversive and Social Stimuli Lead to a
Reduced Animate Exploration, Anxiety-Like
Behavior, and Aggravated Stress Coping
In contrast to the basal anxiety as evaluated in the LDT and
EPM, increasing the aversiveness of the environment by bright
illumination or inescapable stress as well as applying a social
exploratory stimulus led to behavioral alterations in the TPH2-
CB1−/− mice as compared to the TPH2-CB1+/+ littermates.
Even though the first contact with the food pellet was not
altered in the NSF paradigm, the TPH2-CB1−/− mutants showed
an increased latency to start eating the food pellet (delay of first
contact [T(44) = 0.5774; p = 0.5666]; delay of eating [T(44) = 2.112;
p < 0.05]; Figure 3C). Moreover, the TPH2-CB1−/− animals
displayed an increase in digging events and time spent digging,
but no alterations in interaction frequency (digging events [T(43)
= 2.774; p < 0.01]; time spent digging [T(43) = 2.465; p < 0.05];
Figure 3D). At the same time, food consumption in the first 5
min directly after the experiment did not differ between wild
types and mutants (TPH2-CB1+/+: 0.1762 ± 0.02264 g, n = 21;
TPH2-CB1−/−: 0.2070± 0.02789 g, n = 23; p = 0.4020).
The inescapable stress in the FST induced a significant
decrease in time spent immobile, termed as floating behavior
(T(42) = 2.033; p < 0.05; Figure 3E). To address whether
the hypothalamus-pituitary-adrenal axis is affected, we also
measured corticosterone levels in unstressed (no FST) and
stressed conditions (5 min after FST). Stress increased the
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FIGURE 2 | Verification of 5-hydroxytryptamine (5-HT) neuron-specific CB1 loss by in situ hybridization (ISH). (A,D) Overview of the dorsal raphe
nucleus (DRN) double-stained for CB1 (red staining) and TPH2 (blue staining) in TPH2-CB1+/+ (A) and TPH2-CB1−/− (D) mice. TPH2 probes were used to define
serotonergic neurons. (B,E) Higher magnification of coronal hindbrain sections showing presence or absence of CB1 mRNA in serotonergic neurons in
TPH2-CB1+/+ (B) and TPH2-CB1−/− (E) mice. Note that the low expression levels of CB1 (2–7 red dots in a cross-section of a serotonergic neuron) make
visualization of coexpression possible only at high magnification (see inserts). In TPH2-CB1−/− mice, less than 1 in 100 serotonergic cell expressed CB1. (B1–B3)
Serotonergic neurons expressing CB1 mRNA and (C) a CB1-positive, non-serotonergic neuron in TPH2-CB1+/+. (E1–E3) Serotonergic neurons are devoid of CB1
mRNA in TPH2-CB1−/− mice, but CB1-positive, TPH2-negative neurons (F) are still present. Arrows, Fast Red alkaline phosphatase substrate, representing CB1
mRNA localization.
corticosterone levels significantly in both genotypes (TPH2-
CB1−/− [T(17) = 9.892; p < 0.001]; TPH2-CB1+/+ [T(18) =
8.490; p = 0.001]; Figure 3F). However, no significant differences
between genotypes were observed in either of the two conditions
(unstressed [T(17) = 0.9445; p = 0.3581]; stressed [T(18) = 1.511;
p = 0.1482]; Figure 3F).
The introduction of a social interaction partner in the
sociability paradigm revealed a decrease in the time spent in the
compartment with the interaction partner for the TPH2-CB1−/−
mice as compared with their TPH2-CB1+/+ control littermates
(T(37) = 2.339, p < 0.05; Figure 4A). While the time spent
in the middle compartment did not differ between genotypes,
mutant mice spent significantly more time in the compartment
with the empty cage, i.e., with the object (object [T(37) = 2.220,
p < 0.05]; middle [T(37) = 0.4305, p = 0.6693]; Figure 4A).
This is underlined by the significant difference between the
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FIGURE 3 | Anxiety and stress response. No genotype differences were observed in basic anxiety tests, such as (A) the light dark test (LDT) and (B) the
elevated plus maze (EPM). (C) Increased aversive environment in the novelty suppressed feeding (NSF) test induced anxiety-like behavior in TPH2-CB1−/− mice.
Although no genotype differences were observed in the time required for the first contact, mutants showed a delayed time to start eating. (D) While the frequency
of interactions with the food pellet was not altered, a significant increase in the percentage of time spent digging was observed. (E) Mutants displayed a decreased
floating behavior in the forced swim test (FST) as compared with control littermates. (F) No genotype differences were observed in plasma corticosterone
concentrations, neither in basal conditions (non-stressed) nor 5 min after the FST (stressed). Risk asses = risk assessment; LC = lit compartment; n[EPM+LD] = 41
WT + 49 KO; n[NSF ] = 32 WT + 33 KO; n[FST ] = 20 WT + 22 KO; ∗p < 0.05.
two genotypes regarding social preference (T(37) = 2.367,
p< 0.05).
Next, we performed the same test with heterozygous
TPH2CreERT2tg/+ and their wild-type littermates in order to test
a potential behavioral effect induced by the CreERT2 transgene.
No difference was observed between the genotypes for the time
spent in the different compartments (Figure 4B), excluding
the possibility that the behavioral alterations observed above in
TPH2-CB1−/− mice are caused by the Cre transgene.
The analyses of the NORT revealed no genotype differences,
neither in general object exploration nor in object recognition
(object exploration [F(1,63) = 0.6438; p = 0.4253]; object
recognition [F(1,63) = 1.459; p = 0.2316]; Figure 4C). Time of
exploration significantly decreased over the three phases of the
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FIGURE 4 | Social and object exploration. (A) In the sociability test, social exploration was reduced in mutant animals, whereas object exploration was
increased as compared with control littermates. (B) In contrast to TPH2-CB1−/− mice, mice only possessing the CreERT2 transgene (TPH2CreERT2tg/+) did not
show any behavioral alterations in the sociability paradigm as compared to their wild-type littermates. (C) No genotype differences were observed in the novel
object recognition test (NORT), as both groups spent an equal amount of time exploring the objects. (D) The resident intruder (RI) test revealed that the social
interaction initiated by mutant mice was reduced compared to control littermates. This reduction did not depend on the behavior of the C57BL/6N intruder as
intruders showed the same interaction time towards both groups of residents. n[Sociability] = 18 WT+ 21 KO; n[NORT] = 12 WT + 11 KO, n[RI] = 30 WT + 30 KO;
n[CreERT2] = 14 WT + 15 KO; 2-Way ANOVA with Bonferroni’s post hoc test; ∗p < 0.05.
NORT (F(2,63) = 5.243; p < 0.01). However, Bonferroni post-
test analysis revealed only a significant difference for the TPH2-
CB1−/− mice when comparing training and 24 h retention phase
(T(63) = 2.413; p < 0.05). A similar situation was observed for
object recognition as time significantly affected the recognition
index (F(2,63) = 15.81; p < 0.001). Here, Bonferroni post-test
analysis showed significant changes for both genotypes, TPH2-
CB1−/− (training vs. 24 h [T(63) = 3.432; p < 0.01) and TPH2-
CB1+/+ (training vs. 24 h [T(63) = 4.545; p < 0.001]; 2 h vs. 24 h
[T(63) = 2.494; p< 0.05]).
Similarly to the sociability test, in the resident intruder
(RI) paradigm, TPH2-CB1−/− mice (residents) also displayed
a significantly decreased time interacting with the social
interaction partner as compared with their control wild-
type littermates (interaction-absolute time [T(56) = 2.178;
p < 0.05]; Figure 4D). No difference was observed in the
interaction induced by the intruder (interaction-absolute time
[T(56) = 0.9704; p = 0.3360]; Figure 4C). There were no
genotype differences detectable regarding the number of fights
(0.933 ± 0.3864 for TPH2-CB1−/− [n = 30] and 1.286 ± 0.4766
for TPH2-CB1+/+ [n = 28]; T(56) = 0.5779; p = 0.5657) and the
delay until the first fight occurred (539.4 ± 22.55 s for TPH2-
CB1−/− [n = 30] and 487.9 ± 35.2 s for TPH2-CB1+/+ [n = 28];
T(56) = 1.249; p = 0.2160).
Discussion
In this study, we demonstrated that specific deletion of CB1
receptor in central serotonergic neurons leads to distinct
behavioral alterations, which emerged only under stressful
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situations, while no behavioral differences were observed in
basal locomotion and anxiety paradigms under low levels of
stress.
More aversive environments or inescapable stress as displayed
in the NSF paradigm and FST, respectively, induced subtle but
significant behavioral changes. In the NSF paradigm, TPH2-
CB1−/− mice required more time to start eating and spent
more time digging as compared with control mice. The NSF
paradigm was established as an anxiety test to measure the
rodent’s aversion to eat in a novel environment. The test is
sensitive to acute administration of anxiolytic drugs, such as
benzodiazepines, which induce a decreased delay in approaching
and eating the food pellet (Belzung et al., 1987). Additionally, the
increased digging behavior observed for the TPH2-CB1−/− mice
might indicate a stereotypic response in this stressful situation
to the high aversive and emotional distress (Pietropaolo et al.,
2011). An alternative explanation for this phenotype could be a
decreased drive to eat in TPH2-CB1−/− mice. However, we could
not observe any differences in the immediate food intake after the
NSF between wild types and mutants.
In contrast, the decreased time spent immobile in the
FST might be regarded to be an anti-depressive-like behavior,
as antidepressant drugs induce higher mobility in this test
(Borsini andMeli, 1988; Petit-Demouliere et al., 2005). However,
this particular effect might be caused by multiple underlying
mechanisms (Petit-Demouliere et al., 2005). One explanation
might be an unbalanced stress coping based on an increased fear
level. In fact, the parallel presence of increased anxiety-like and
anti-depressive-like responses in the FST was previously seen in
5-HT1A receptor deficient mice (Heisler et al., 1998) and in mice
lacking the CB1 receptor in cortical glutamatergic neurons (Glu-
CB1−/−; Steiner et al., 2008; Jacob et al., 2009; Häring et al., 2011,
2012, 2013). Therefore, the decreased immobility time in the FST
may rather be interpreted as an alteration in stress coping than
as an anti-depressive-like behavior. However, it is interesting to
note that plasma corticosterone levels after FST were not higher
in TPH2-CB1−/− mice than in control mice, which constitutes
a similar phenotype as reported previously for the Glu-CB1−/−
mice (Steiner et al., 2008). An anxiety-like phenotype is apparent
by the decreased time that TPH2-CB1−/− mice spent with a
social interaction partner in the sociability test and RI paradigm.
Notably, the investigatory drive itself seems to be unaltered,
as no genotype differences were observed neither in the time
spent in the middle compartment of the sociability box nor in
the object exploration in the NORT. Thus, these data suggest
a decreased interest in a social stimulus in the TPH2-CB1−/−
mice, which can be interpreted as an anxiety-like phenotype.
The environmental conditions appear to be very important in
the behavioral outcomes observed in TPH2-CB1−/− mice. While
in another study TPH2-CB1−/− mice showed increased anxiety
in the EPM (Dubreucq et al., 2012) when performing the assay
in the light phase, we did not see genotype differences when
performing the assay in the dark phase. This is consistent with
our notion that the phenotype of TPH2-CB1−/− mice is sensitive
to environmental stress conditions.
Although so far we have not been able to provide direct
evidence of an increased serotonergic drive in TPH2-CB1−/−
mice, the inactivation of the CB1 receptor gene presumably
increases serotonergic neurotransmission in a long-term
manner. This expectation appears to contradict the phenotype
observed. We found that the deletion of the CB1 receptor from
central serotonergic neurons alters the behavioral performance
in response to stress, causing an anxiety-like and anti-social
phenotype. It is well established that 5-HT is crucially involved
in a multitude of behavioral responses, most importantly in
emotion and social interaction (Cools et al., 2008; Waider et al.,
2011). Based on the behavioral changes observed after blocking
SERT function leading to increased serotonergic drive, 5-HT
has normally been associated with a decrease in fear and stress
response (Williams et al., 2010; Haenisch and Bönisch, 2011).
However, accumulating evidence suggests more diverse effects
of chronic 5-HT excess (Haenisch and Bönisch, 2011). Genetic
and pharmacological inhibition of SERT can lead to an elevated
anxiety level as well as to a reduced aggression in mice (Heiming
et al., 2009; Jansen et al., 2010, 2011; Homberg and Lesch, 2011).
It is interesting to mention that an appropriate serotonergic
tone is required for normal anxiety behavior, as both excess (see
above) and lack of 5-HT (Jia et al., 2014) emerge to a comparable
phenotype, i.e., increased anxiety.
At the anatomical level, it can only be hypothesized how
CB1 receptor in 5-HT neurons mediate behavioral alterations.
According to our previous findings, sparse CB1 receptor-positive
serotonergic fibers were observed in cortical areas including
hippocampus and amygdala. Both regions are essential for
appropriate emotional behavioral responses, coping with anxiety
and stress in particular. The PFC–DRN circuits are highly
complex, with identifiable cell-type specific connectivity patterns
(Pollak Dorocic et al., 2014) and activity patterns that are
regulated not only by 5-HT, but glutamate and γ-aminobutyric
acid (GABA) as well (Celada et al., 2001). Moreover, different
classes of (topologically distinct) 5-HT receptors make it possible
for DRN neurons to either stimulate or inhibit their target cells
(Celada et al., 2013). In addition, the molecular diversity of 5-HT
neurons adds a further level of complexity to the regulation of
their activity. For example, a portion of 5-HT neurons expresses
vesicular glutamate transporter VGlut3 (Amilhon et al., 2010)
and a subpopulation of 5-HT neurons lack the inhibitory 5-HT1A
autoreceptor (Kiyasova et al., 2013). All these interconnected
regulatory mechanisms enable that 5-HT release in the DRN and
the projection areas can be differentially regulated (Coplan et al.,
2014). How also eCB mediated transmitter release adds to the
complexity of this picture we are just beginning to understand.
Presence of CB1 in the hippocampus and amygdala at 5-HT
synapses (Häring et al., 2007) means that activity-related down-
regulation of 5-HT release may be possible at these sites.
In summary, we could demonstrate the physiological
relevance of the CB1 receptor in central serotonergic neurons
presumably fine tuning 5-HT transmission. Our findings are in
line with recent insights on 5-HT function changing the dogma
that 5-HT mediates predominantly positive emotional effects.
Thus, the chronic desensitization of serotonergic signaling seems
to induce negative emotional changes (Canli and Lesch, 2007;
Homberg and Lesch, 2011). Psychiatric disorders such as autism
spectrum disorders and schizophrenia are often associated with
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similar behavioral changes, such as decreased social interaction,
depression and anxiety. In fact, 5-HT reuptake inhibitors are
often used to treat depressive and anxiety symptoms, although
the clinical effectiveness has remained elusive (Williams et al.,
2010). Nevertheless, these types of drugs are highly potent in
the treatment of depression disorders, suggesting that psychiatric
diseases might be based on more complex physiological
alterations, requiring a complex intervention approach. Our
data indicate a contributing role of central serotonergic CB1
receptor in the effects on mood and emotional states. These
effects might have influenced the anxiety/depression side effects
of chronic application of the CB1 receptor antagonist rimonabant
(Moreira et al., 2009). On a more positive note, this notion also
indicates that combined pharmacotherapies targeting both the
serotonergic and the eCB system might potentially be applied to
treat stress-related emotional disturbances.
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